Randomized Trial of Fascia Lata and Polypropylene Mesh for Abdominal Sacrocolpopexy: 5-year Follow-up
Overview
Urology
Affiliations
Introduction And Hypothesis: The purpose of this study is to evaluate the 5-year surgical outcomes of abdominal sacrocolpopexy among subjects randomized to receive polypropylene mesh or cadaveric fascia lata.
Methods: All 100 subjects from the original randomized clinical trial were eligible. Primary outcome was objective anatomic failure: any pelvic organ prolapse quantification (POP-Q) point ≥ - 1. Secondary outcome was clinical failure-presence of bulge or prolapse symptoms and either a POP-Q point C ≥ ½ TVL or any POP-Q point >0-and interim surgical re-treatment. Wilcoxon tests and Fisher's exact test were performed.
Results: Fifty-eight subjects returned for 5-year follow-up-29 mesh and 29 fascia. Objective anatomic success rates were: mesh, 93% (27/29) and fascia, 62% (18/29) (p = 0.02). Clinical success rates were: mesh, 97% (28/29) and fascia, 90% (26/29) (p = 0.61).
Conclusions: Polypropylene mesh was superior to cadaveric fascia lata using objective anatomic outcomes. Success rates of mesh and fascia were comparable using a clinical definition that combined symptoms with anatomic measures.
Sacrocolpopexy: Alternatives to Mesh Grafts.
Yong C, Raoofi M, Carey M Int Urogynecol J. 2024; 36(1):3-10.
PMID: 39476292 DOI: 10.1007/s00192-024-05956-4.
Cadiz M, Aguinaldo J Acta Med Philipp. 2024; 58(11):46-53.
PMID: 39006991 PMC: 11239997. DOI: 10.47895/amp.v58i11.8968.
Narrative review of flaps and grafts in robotic reconstructive urologic surgery.
Doersch K, Hines L, Ajay D Ann Laparosc Endosc Surg. 2024; 9.
PMID: 38938988 PMC: 11210586. DOI: 10.21037/ales-23-36.
Surgery for women with apical vaginal prolapse.
Maher C, Yeung E, Haya N, Christmann-Schmid C, Mowat A, Chen Z Cochrane Database Syst Rev. 2023; 7:CD012376.
PMID: 37493538 PMC: 10370901. DOI: 10.1002/14651858.CD012376.pub2.
Robotic Sacrocolpopexy with Autologous Fascia Lata: A Case Series.
Damiani G, Villa M, Falcicchio G, Cesana C, Malvasi A, Picardi N Gynecol Minim Invasive Ther. 2023; 12(1):10-14.
PMID: 37025435 PMC: 10071871. DOI: 10.4103/gmit.gmit_7_22.